Structure-activity relationships of kadsurenone analogues

Area of Science:

• Medicinal Chemistry
• Pharmacology

Background:

• Platelet-activating factor (PAF) is a key mediator in inflammatory and allergic responses.
• Developing specific PAF receptor antagonists is crucial for therapeutic interventions.

Purpose of the Study:

• To synthesize kadsurenone and its analogues.
• To evaluate their potency as platelet-activating factor (PAF) receptor antagonists.
• To investigate the structure-activity relationship of these compounds.

Main Methods:

• Synthesis of kadsurenone and analogues from cinnamyl alcohol and (allyloxy)phenol derivatives.
• Chiral separation of racemic kadsurenone using a Chiralpak column at low temperatures.
• In vitro assessment of PAF receptor-blocking activity using IC50 values.

Main Results:

• Synthetic racemic kadsurenone exhibited an IC50 value of 2 x 10(-7) M, approximately 50% of natural kadsurenone's activity (IC50 = 1 x 10(-7) M).
• Structural modifications, including denudatin B, mirandin A, desallylkadsurenone, and the 2-epimer, showed significantly reduced PAF receptor-blocking activities.
• The study confirmed the structural specificity of kadsurenone for PAF receptor antagonism.

Conclusions:

• Kadsurenone and its analogues can be synthesized and possess PAF receptor antagonist properties.
• The synthetic route provides a basis for developing novel PAF antagonists.
• Structural features of kadsurenone are critical for its potent PAF receptor-blocking activity.